DNA sequencing firm's second act gets mixed reviews

Plug and play. Soon researchers will have a chance to put a new hand-held sequencer through its paces.


DNA Sequencing Firm's Second Act Gets Mixed Reviews

Two years ago, Oxford Nanopore Technologies demonstrated a revolutionary new sequencing technology at a meeting for genomicists, but it's taken until now for it to show more data and to begin to share its new cheap, hand-held device with researchers. Meanwhile, Illumina, by far the biggest maker of sequencing machines, is about to introduce a 10-machine system that can produce 18,000 human genomes per year for less than $1000 a piece. But the machines cost $1 million apiece. Both promise to change the face of sequencing.

For the full story, see this week's issue of Science.